Indaptus director Lu Qinglai files Form 3

Indaptus Therapeutics, Inc. director Lu Qinglai filed an initial Form 3, which is a statement of beneficial ownership for company insiders.

Accepted by SEC EDGAR 04/20/2026 - 04:05 PM EDT Learn about SEC filing dates

Rhea-AI Filing Summary

Indaptus Therapeutics, Inc. director Lu Qinglai filed an initial Form 3, which is a statement of beneficial ownership for company insiders. This filing lists no transactions and shows no reported purchases, sales, or derivative exercises by the reporting person in the data provided.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What does the Indaptus (INDP) Form 3 filing for Lu Qinglai show?

The Form 3 for Indaptus director Lu Qinglai is an initial ownership report. In the data provided, it lists no transactions, with zero reported purchases, sales, or exercises and no derivative positions disclosed.

Does the Indaptus (INDP) Form 3 report any insider buying or selling?

No. The transaction summary in this Indaptus Form 3 shows zero buy and zero sell transactions, with net buy/sell shares reported as 0, indicating no trading activity in this filing’s data.

Who is the reporting person in this Indaptus (INDP) Form 3?

The reporting person is Lu Qinglai, identified as a director of Indaptus Therapeutics, Inc. The filing characterizes Lu as a board member, with no officer role or 10% ownership status indicated in the data provided.

What is the purpose of this Indaptus (INDP) Form 3 filing?

This Form 3 serves as an initial statement of beneficial ownership for director Lu Qinglai at Indaptus Therapeutics, Inc. It establishes insider status and provides a baseline for future Form 4 or Form 5 transaction reporting.

Are any derivative securities reported in the Indaptus (INDP) Form 3?

No. The derivative summary in this Indaptus Form 3 is empty, and the derivativeTransactionCount is 0, indicating that no options, warrants, or other derivative securities are reported in the provided data.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Understanding Insider Trading Forms →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

SEC Form 3

FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0104
Estimated average burden
hours per response:			0.5

1. Name and Address of Reporting Person^*

Lu Qinglai

(Last) (First) (Middle)

C/O INDAPTUS THERAPEUTICS, INC.

3 COLUMBUS CIRCLE, 15TH FLOOR

(Street)

NEW YORK NEW YORK 10019

(City) (State) (Zip)

UNITED STATES

(Country)

2. Date of Event Requiring Statement (Month/Day/Year)
04/08/2026

3. Issuer Name and Ticker or Trading Symbol
Indaptus Therapeutics, Inc. [ INDP ]

3a. Foreign Trading Symbol

5. If Amendment, Date of Original Filed (Month/Day/Year)

4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

No securities are beneficially owned.

	/s/ Qinglai Lu	04/20/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 3: SEC 1473 (03-26)